Proactive - Interviews for investors

Wedgemount Resources CEO Mark Vanry joined Steve Darling from Proactive to provide an update to Proactive on the company's field activities at its recently acquired Huggy Assets. After weather-related delays, Wedgemount has full operations going, including pumping, surface facility optimization, maintenance, chemical treatments, and well workovers.

The company's primary focus remains on the Echo and Novice operational areas, where five additional wells have been brought back online. These wells had been inactive for a significant period before Wedgemount's acquisition. Historical initial production (IP) rates for these wells ranged from 15 to 65 barrels of oil equivalent per day (boepd).

Vanry noted that previous successful chemical stimulations on Wedgemount’s Willowbend leases resulted in improved well performance. The company expects similar or better results from workovers and chemical treatments at Huggy, potentially exceeding the original IP rates.

Looking ahead, Wedgemount has over 100 additional wells that have yet to undergo chemical stimulation, presenting significant production upside over the next two years.

#proactiveinvestors #westmountreosurcescorp #cse #wdgy #otcqb #wdgrf #OilProduction #TexasEnergy #EnergyInvesting #OilandGas #MarkVanry #ProactiveInvestors #EnergyStocks #Investing #OilExploration

Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF) chairman Domenic Carosa talked with Proactive's Stephen Gunnion about Hivello’s latest integration with the Nosana network. Carosa explained that Hivello allows users to rent out their computer resources, similar to how AirBnB operates for homes. This model enables users to generate passive income while contributing to a decentralized blockchain network.

The integration with Nosana enhances this model by tapping into AI demand. “Nosana is one of the leading GPU DePINs… they basically power AI,” Carosa said. He highlighted that Hivello’s users are now actively contributing to training AI models and earning from it.

Carosa also discussed the recent token generation event (TGE), comparing it to an IPO in the crypto space. As of the interview, Hivello’s token had a fully diluted value of over $20 million, providing significant value to Blockmate Ventures, which owns approximately 50% of Hivello.

Looking ahead, Blockmate Ventures is focused on expanding its DePIN integrations and increasing customer adoption. Carosa emphasized that the company is doubling down on AI and blockchain opportunities in 2025.

For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for the latest insights!

#BlockmateVentures #Hivello #Nosana #AI #DePIN #Crypto #Blockchain #TokenGeneration #Web3 #PassiveIncome #TechInvesting

Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy joined Proactive's Stephen Gunnion with details about the company's latest milestone—the successful prototyping of its 50Ah Goliath EV battery. This marks a significant leap from the previous 2Ah prototype, representing a 25-fold increase in capacity.

Purdy highlighted the importance of scaling up production to meet industry requirements. "We need to make sure that we've got reproducibility. What industry needs is not just a few successful cells but large-scale, reliable production," he said.

Ilika has benefited from £2.8 million in grant funding through the Faraday Battery Challenge, which Purdy noted has effectively doubled the impact of investor funding. In parallel, Ilika has also demonstrated its manufacturing process at a giga-scale setting through a partnership with the UK Battery Industrialisation Centre (UKBIC).

Looking ahead, the company plans to complete its 1.5MWh per year pilot line with automated equipment. Key upcoming milestones include releasing P1.5 prototypes in the summer and the full P2 release by year-end.

Stay tuned for more updates on Ilika’s Goliath program. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for future updates.

#IlikaPLC #EVBatteries #SolidStateBatteries #BatteryTechnology #EnergyStorage #RenewableEnergy #ElectricVehicles #BatteryInnovation #TechInvesting #ProactiveInvestors

Graphene Manufacturing Group CEO Craig Nicol joined Steve Darling from Proactive to share an update as the company continues to make strides in the development of its Graphene Aluminium-Ion Battery technology, a cutting-edge innovation being pursued in collaboration with the University of Queensland and Rio Tinto under a Joint Development Agreement.

Nicol told Proactive, to accelerate battery development, GMG has signed a service contract with the Battery Innovation Center (BIC) in Indiana, USA. This partnership will support the next phase of research and optimization, leveraging BIC’s state-of-the-art 40,000-square-foot facility in Newberry, Indiana. As a globally recognized innovation hub, BIC specializes in advancing battery technologies, offering end-to-end support from research and development to prototype manufacturing and low-volume production—a critical advantage for GMG as it scales up its graphene-based energy storage solutions.

Nicol emphasized that collaborating with BIC allows GMG to access advanced battery manufacturing infrastructure without incurring the high capital costs of building its own pilot production facility—an investment that could exceed AU$10 million. Through this agreement, GMG will retain full intellectual property (IP) rights over the battery development work, ensuring control over its proprietary technology while optimizing BIC’s cell design expertise and battery manufacturing capabilities.

By integrating BIC’s expertise into its scale-up strategy, GMG can streamline the production of sample battery cells before committing to mass production, reducing risks and deferring large capital expenditures until the technology reaches a higher level of readiness. Looking ahead, GMG aims to optimize battery performance, produce initial test cells this year, and engage customers for validation. Nicol noted strong interest from major companies eager to integrate this technology.

#proactiveinvestors #graphenemanufacturinggroupltd #BatteryTech #FastCharging #GMG #RioTinto #EnergyInnovation #CleanTech #BatteryInnovation #EVBatteries #GreenEnergy #GrapheneBatteries

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025.

In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment.

This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care.

#proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce a strategic partnership with CSM.ai, a leading team of AI researchers, product innovators, and digital artists. This collaboration aims to advance the creation of high-quality, cost-efficient 3D models at scale, providing businesses with next-generation product visualization technology.

Nextech3D.ai and CSM.ai began working together in early 2025, successfully delivering hundreds of 3D models to customers with faster turnaround times and reduced costs. The partnership enhances Nextech3D.ai’s automated 3D modeling pipeline while leveraging CSM.ai’s deep AI expertise. At the same time, CSM.ai benefits from Nextech3D.ai’s extensive experience in 3D e-commerce applications.

By combining resources, the companies aim to further scale production, drive down costs, and unlock new opportunities in the evolving 3D visualization industry, delivering substantial value to businesses and consumers alike.

#nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #AmazonSellerCentral #3DModeling #AIPhotography #EcommerceInnovation #3DTechnology #LifestylePhotography #ProactiveInterviews #TechInnovation #AmazonPartners#proactiveinvestors #nextech3d.al

Synchronoss Technologies is expanding its cloud offerings with the launch of Capsyl Cloud, a next-generation personal cloud platform designed to help mobile operators and broadband providers quickly deploy secure, scalable, and revenue-generating cloud services. CEO Jeff Miller spoke with Steve Darling from Proactive and the company introduced the new platform at Mobile World Congress in Spain, The company highlighted its potential to transform how users store, manage, and protect their digital content.

Capsyl Cloud is a turnkey, cross-platform solution that enables seamless access to photos, videos, documents, audio, contacts, and messages across smartphones, tablets, laptops, and desktops. Unlike traditional storage solutions, Capsyl Cloud leverages AI-powered tools to enhance how users organize, search, and optimize their digital memories. Features include AI-driven photo search capabilities, offering a more intuitive and personalized cloud experience.

Developed through extensive beta testing since 2022, Capsyl Cloud is now entering the market with its first major deployment by Telkomsel, Indonesia’s largest mobile network operator. This partnership makes Capsyl Cloud available to millions of Telkomsel’s prepaid and postpaid subscribers, marking a significant milestone in Synchronoss’s strategy to bring innovative cloud solutions to global telecom providers.

With Capsyl Cloud, Synchronoss continues to push the boundaries of AI-enhanced cloud technology, providing both users and service providers with a secure, intuitive, and future-ready digital storage solution.

#proactiveinvestors #synchronosstechnologiesinc #nasdaq #sncr @cloud #CapsylCloud #AI #MobileWorldCongress #CloudTechnology #MachineLearning #TechInnovation #Telecom #DigitalTransformation #MWC2025

Immunic Therapeutics chief medical officer Dr Andreas Muehler talked with Proactive's Stephen Gunnion about the company's strong presence at the 10th annual ACTRIMS Forum, where it presented two key posters on multiple sclerosis (MS). He highlighted that Immunic’s investigational drug, vidofludimus calcium, has potential neuroprotective properties that may benefit both relapsing and progressive MS patients.

One of the posters examined baseline characteristics of past progressive MS trials and contrasted them with Immunic’s CALLIPER trial, designed for non-relapsing patients with minimal inflammatory activity. The second poster explored preclinical data on the drug’s mechanism of action, emphasizing its potential to target activated microglia and support neuron survival.

Muehler noted significant engagement from the MS community at ACTRIMS, with many keenly anticipating the CALLIPER trial’s readout in April. “It’s really one of the very few late-stage drugs with a potential neuroprotective effect,” he said, adding that the data could provide new hope for progressive MS patients who currently have limited treatment options.

Stay tuned for more updates on Immunic’s progress. For more interviews, subscribe to Proactive’s YouTube channel, like this video, and turn on notifications!

#ImmunicTherapeutics #MSResearch #Neuroprotection #CALLIPERTrial #MultipleSclerosis #Biotech #DrugDevelopment #ClinicalTrials #MedicalBreakthrough #ACTRIMS

Lavras Gold Corp. President & CEO Michael Durose talked with Proactive's Angela Harmantas from the PDAC conference on Toronto about the company’s latest developments at the Lavras do Sul (LDS) Project in Brazil. The company, a gold exploration firm, currently holds around 1 million ounces across two of 24 exploration targets.

Durose outlined the key 2024 milestones, including 17,000 meters of drilling across key areas such as Butiá, Fazenda do Posto, and Caneleira. A major highlight was the Almeria discovery, where drilling intersected 56 meters at 1 gram per ton of gold from surface.

Looking ahead, Lavras Gold is focused on infill drilling at Butiá to define a potential mineable resource and step-out drilling at Fazenda do Posto to determine the mineralization limits. The company is also conducting metallurgical test work at Butiá, which will later extend to Fazenda do Posto.

Durose emphasized that additional drilling results and exploration at Caneleira will be major catalysts for the company in 2024, potentially expanding the known mineralization footprint.

#LavrasGold #GoldExploration #MiningNews #GoldStocks #BrazilMining #JuniorMining #DrillResults #GoldDiscovery #Investing #MiningInvestments

National Stock Exchange of Australia CEO Max Cunningham talked with Proactive's Angela Harmantas from the PDAC conference in Toronto about the exchange’s role in the Australian market, its focus on mining companies, and its expansion plans.

Cunningham explained that the NSX is one of two active stock exchanges in Australia with a tier-one license, allowing it to serve all investors, including retail. He highlighted that around one-third of the exchange’s listings are mining-related, with strong growth potential in the sector.

Cunningham noted that NSX is working to fill a gap in the Australian venture market and is focusing on attracting mining companies, especially from regions like Perth. He also emphasized the importance of international relationships, mentioning cross-listing agreements with Canadian exchanges such as the CSE and TSX, as well as OTC Markets.

Looking ahead to 2025, Cunningham discussed the challenges of IPOs due to regulatory hurdles and capital-raising difficulties. Instead, the NSX is prioritizing direct listings, which allow companies to go public without raising capital upfront. He stated that NSX is seeing increased interest from firms moving from the incumbent Australian exchange, as well as from Canadian companies seeking dual listings.

#NSX #StockMarket #MiningStocks #IPOs #DirectListings #PDAC2025 #Investing #AustralianMarkets #DualListings #CapitalMarkets